Cell Source, Inc.
CLCS · OTCMCIK 1569340fmd_0MAZ9JR09E1GXWXY72MMEMMWBJManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2012 to Mar 31, 2025, 50 periods
Latest annual · FY2024
Millions- Operating income
- (4)
- Net income
- (5)
Latest quarter · Q1 FY2025
Millions- Operating income
- (1)
- Net income
- (1)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2019 to FY2024
- n/m
Cell Source, Inc. (CLCS) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Operating income | -$3.8 million | -$4.3 million | 10-K 2026-04-07 · proof | |
| Net income | -$4.5 million | -$5.3 million | 10-K 2026-04-07 · proof | |
| Cash from operating activities | -$2.7 million | -$2.3 million | 10-K 2026-04-07 · proof | |
| Total assets | $286,500 | $195,171 | +46.8% | 10-K 2026-04-07 · proof |
| Total liabilities | $18.8 million | $15.8 million | +19.1% | 10-K 2026-04-07 · proof |
| Cash and cash equivalents | $74,631 | $22,203 | +236.1% | 10-K 2026-04-07 · proof |
- What was Cell Source, Inc. (CLCS)'s operating income in fiscal 2024?
- Cell Source, Inc. (CLCS) reported operating income of -$3.8 million for fiscal 2024 (the year ended Dec 31, 2024), against -$4.3 million the year before. Source: the 10-K filed with the SEC on Apr 7, 2026. SEC
- What was Cell Source, Inc. (CLCS)'s net income in fiscal 2024?
- Cell Source, Inc. (CLCS) reported net income of -$4.5 million for fiscal 2024 (the year ended Dec 31, 2024), against -$5.3 million the year before. Source: the 10-K filed with the SEC on Apr 7, 2026. SEC
- What was Cell Source, Inc. (CLCS)'s cash from operating activities in fiscal 2024?
- Cell Source, Inc. (CLCS) reported cash from operating activities of -$2.7 million for fiscal 2024 (the year ended Dec 31, 2024), against -$2.3 million the year before. Source: the 10-K filed with the SEC on Apr 7, 2026. SEC
- What are Cell Source, Inc. (CLCS)'s total assets?
- As of Dec 31, 2024, Cell Source, Inc. (CLCS) reported total assets of $286,500, against $195,171 a year earlier (+46.8%). Source: the 10-K filed with the SEC on Apr 7, 2026. SEC
- What are Cell Source, Inc. (CLCS)'s total liabilities?
- As of Dec 31, 2024, Cell Source, Inc. (CLCS) reported total liabilities of $18.8 million, against $15.8 million a year earlier (+19.1%). Source: the 10-K filed with the SEC on Apr 7, 2026. SEC
- What are Cell Source, Inc. (CLCS)'s cash and cash equivalents?
- As of Dec 31, 2024, Cell Source, Inc. (CLCS) reported cash and cash equivalents of $74,631, against $22,203 a year earlier (+236.1%). Source: the 10-K filed with the SEC on Apr 7, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:CLCS&period_type=annual&limit=5"Information only, not investment advice.